10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,558,325 | +59.9% | 62,020 | +116.5% | 0.01% | +16.7% |
| Q2 2023 | $1,599,648 | +635.2% | 28,647 | +634.5% | 0.01% | +100.0% |
| Q1 2023 | $217,581 | -17.1% | 3,900 | -45.8% | 0.00% | -40.0% |
| Q4 2022 | $262,368 | -61.9% | 7,200 | +104.8% | 0.01% | -78.3% |
| Q2 2021 | $689,000 | -19.3% | 3,516 | -25.5% | 0.02% | -53.1% |
| Q1 2021 | $854,000 | -45.7% | 4,718 | -57.5% | 0.05% | -53.3% |
| Q4 2020 | $1,574,000 | +42.1% | 11,114 | +25.1% | 0.10% | -14.6% |
| Q3 2020 | $1,108,000 | +413.0% | 8,884 | +266.7% | 0.12% | +156.2% |
| Q2 2020 | $216,000 | – | 2,423 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |